UBM Medica US announces that Psychiatric Times, a leading online community for mental health professionals, introduces the latest information on anxiety disorders.
A new Special Report reviews the latest pharmacological strategies for anxiety, comorbid anxiety and schizophrenia, TMS, and managing anxiety in the medically ill. Featured articles include:
- Pharmacological Strategies for Generalized Anxiety Disorder: Jennifer A. Reinhold, PharmD, BCPS, BCPP reviews treatment approaches to GAD, a highly prevalent, chronic, debilitating, relapsing, and often underdiagnosed anxiety disorder.
- Treating Comorbid Anxiety Disorders in Patients With Schizophrenia: A New Pathway: Amelie M. Achim, PhD, Stephanie Sutliff, MSc, and Marc-Andre Roy, MD, MSc stress the importance of identifying comorbid anxiety disorders as potential treatment targets that may contribute to more positive outcomes for patients with schizophrenia.
- Does TMS Hold Promise for Generalized Anxiety Disorder?: Available data suggest that transcranial magnetic stimulation holds promise as a treatment for anxiety. Gretchen J. Diefenbach, PhD and John W. Goethe, MD take a look at what we know.
Metabolic markers tied to increased risk of depression and anxiety, study finds